Back to Search
Start Over
Serum Cytokine Changes in a Patient with Chronic Pulmonary Aspergillosis Overlapping with Allergic Bronchopulmonary Aspergillosis.
- Source :
-
Internal medicine (Tokyo, Japan) [Intern Med] 2024 Jun 01; Vol. 63 (11), pp. 1659-1664. Date of Electronic Publication: 2023 Oct 27. - Publication Year :
- 2024
-
Abstract
- Allergic bronchopulmonary aspergillosis (ABPA) and chronic pulmonary aspergillosis (CPA) are diseases caused by Aspergillus infection, and CPA can develop from ABPA in some cases. We herein report a patient with CPA overlapping with ABPA. Serum cytokine levels were evaluated at 4 time points: the ABPA diagnosis, CPA diagnosis, 6 months after the start of voriconazole (VRCZ), and 12 months after re-administration of VRCZ. Interleukin (IL)-13 levels decreased upon glucocorticoid treatment, whereas IL-25 and IL-33 levels decreased rapidly with the initiation of antifungals. Early antifungal therapy may be important to control disease progression and prevent CPA overlap.
- Subjects :
- Humans
Chronic Disease
Antifungal Agents therapeutic use
Male
Middle Aged
Aspergillosis, Allergic Bronchopulmonary blood
Aspergillosis, Allergic Bronchopulmonary drug therapy
Aspergillosis, Allergic Bronchopulmonary diagnosis
Aspergillosis, Allergic Bronchopulmonary complications
Pulmonary Aspergillosis blood
Pulmonary Aspergillosis diagnosis
Pulmonary Aspergillosis drug therapy
Pulmonary Aspergillosis complications
Cytokines blood
Voriconazole therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1349-7235
- Volume :
- 63
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Internal medicine (Tokyo, Japan)
- Publication Type :
- Academic Journal
- Accession number :
- 37899245
- Full Text :
- https://doi.org/10.2169/internalmedicine.2234-23